COVID-19 induced bradyarrhythmia and relative bradycardia: An overview.
COVID‐19
arrythmia
bradyarrhythmia
bradycardia
coronavirus
Journal
Journal of arrhythmia
ISSN: 1880-4276
Titre abrégé: J Arrhythm
Pays: Japan
ID NLM: 101263026
Informations de publication
Date de publication:
Aug 2021
Aug 2021
Historique:
received:
01
03
2021
revised:
06
05
2021
accepted:
24
05
2021
entrez:
13
8
2021
pubmed:
14
8
2021
medline:
14
8
2021
Statut:
epublish
Résumé
Novel coronavirus 2019 (COVID-19) has been the focus of the medical community since its emergence in December 2019 and has already infected more than 100 million patients globally. Primarily described to cause a respiratory illness, COVID-19 has been found to affect almost every organ system. Bradycardia is a newly recognized ramification of COVID-19 that still has unknown prognostic value. Studies have shown an increase in the incidence of arrhythmias, cardiomyopathies, myocarditis, acute coronary syndromes, and coagulopathies in infected patients as well as an increased risk of mortality in patients with preexisting cardiovascular disease. While the pathogenesis of bradycardia in COVID-19 may be multifactorial, clinicians should be aware of the mechanism by which COVID-19 affects the cardiovascular system and the medication side effects which are used in the treatment algorithm of this deadly virus. There has yet to be a comprehensive review analyzing bradyarrhythmia and relative bradycardia in COVID-19 infected patients. We aim to provide a literature review including the epidemiology, pathogenesis, and management of COVID-19 induced bradyarrhythmia.
Identifiants
pubmed: 34386113
doi: 10.1002/joa3.12578
pii: JOA312578
pmc: PMC8339085
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
888-892Informations de copyright
© 2021 The Authors. Journal of Arrhythmia published by John Wiley & Sons Australia, Ltd on behalf of Japanese Heart Rhythm Society.
Déclaration de conflit d'intérêts
Authors declare no conflict of interests for this article.
Références
Int Heart J. 2020 Sep 29;61(5):1056-1058
pubmed: 32921678
J Interv Card Electrophysiol. 2020 Nov;59(2):329-336
pubmed: 32494896
J Cardiovasc Electrophysiol. 2020 May;31(5):1003-1008
pubmed: 32270559
JACC Case Rep. 2020 Nov 18;2(14):2260-2264
pubmed: 33163977
Clin Cardiol. 2020 Jul;43(7):796-802
pubmed: 32562427
Med Hypotheses. 2018 Oct;119:63-67
pubmed: 30122494
Clin Microbiol Infect. 2021 Aug;27(8):1185-1187
pubmed: 33901669
PLoS One. 2021 Feb 11;16(2):e0246732
pubmed: 33571321
Indian Heart J. 2020 Nov-Dec;72(6):593-598
pubmed: 33357651
Heart Rhythm. 2015 Oct;12(10):2186-94
pubmed: 26025323
Cureus. 2020 Jun 13;12(6):e8599
pubmed: 32550090
Cureus. 2020 Oct 24;12(10):e11132
pubmed: 33240723
JAMA. 2020 Mar 17;323(11):1061-1069
pubmed: 32031570
Medicine (Baltimore). 2020 May;99(19):e20207
pubmed: 32384516
Indian Pacing Electrophysiol J. 2020 Sep - Oct;20(5):211-212
pubmed: 32822746
Crit Care. 2020 May 26;24(1):257
pubmed: 32456695
JAMA Cardiol. 2020 Jul 1;5(7):811-818
pubmed: 32219356
Am J Respir Cell Mol Biol. 2021 Jan;64(1):79-88
pubmed: 32991819
Bull Exp Biol Med. 2012 Apr;152(6):692-5
pubmed: 22803166
Cardiovasc Res. 2021 Feb 22;117(3):876-889
pubmed: 32346730
Clin Microbiol Infect. 2021 Feb;27(2):295-296
pubmed: 32822885
Ann Thorac Med. 2020 Jul-Sep;15(3):171-173
pubmed: 32831940
J Am Coll Cardiol. 2020 May 12;75(18):2352-2371
pubmed: 32201335
Circ Arrhythm Electrophysiol. 2021 Mar;14(3):e009458
pubmed: 33554620
Ther Adv Infect Dis. 2013 Oct;1(5):155-65
pubmed: 25165550
Methodist Debakey Cardiovasc J. 2020 Apr-Jun;16(2):146-154
pubmed: 32670475
Pacing Clin Electrophysiol. 2020 Oct;43(10):1199-1204
pubmed: 32820823
Emerg Infect Dis. 2020 Oct;26(10):2504-2506
pubmed: 32610036
Sci China Life Sci. 2020 Mar;63(3):457-460
pubmed: 32009228
Nat Med. 2020 Jul;26(7):1017-1032
pubmed: 32651579
Front Med. 2020 Apr;14(2):185-192
pubmed: 32170560
Toxicol Commun. 2020;4(1):40-42
pubmed: 32457932
N Engl J Med. 2020 Nov 5;383(19):1813-1826
pubmed: 32445440
Clin Microbiol Infect. 2000 Dec;6(12):633-4
pubmed: 11284920